NCT00448838: Cetuximab, Gemcitabine, and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer |
|
|
| Completed | N/A | 42 | US | Cetuximab, C-225, Gemcitabine Hydrochloride, Gemcitabine HCl, Oxaliplatin | University of Miami | Pancreatic Cancer | 08/07 | 03/11 | | |
NCT01760694: Multi-Modality Therapy for Untreated Patients With Resectable or Marginally Resectable Pancreatic Cancer |
|
|
| Terminated | N/A | 6 | US | Multi-Modality; IORT, Surgery, Radiation, Chemotherapy, Intraoperative Radiation Therapy (IORT), Chemotherapy: FOLFIRINOX, Oxaliplatin, Irinotecan, 5-FU, Leucovorin, Surgery: Resectable or Marginally Resectable | Southwestern Regional Medical Center | Pancreatic Cancer | 07/14 | 07/14 | | |